Ser194Leu DSG2 mutation, associated with arrhythmogenic left ventricular cardiomyopathy and ventricular tachycardia
Pacing and Clinical Electrophysiology · 2024-04 · 47 (4) · 503-510
DOI: 10.1111/pace.14950 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2024-02-20. Written by Miry Blich and 13 co-authors. Institution: Cardiology Division, Rambam Health Care Campus, Haifa, Israel. Major MEDLINE topics: Arrhythmogenic Right Ventricular Dysplasia, Cardiomyopathies, Tachycardia, Ventricular. Cited 2 times so far (Crossref); 20 references.
Abstract (original language)
Introduction
Arrhythmogenic cardiomyopathy (AC) is an inherited cardiomyopathy characterized by fibro‐fatty replacement of cardiomyocytes, leading to life‐threatening ventricular arrhythmia and heart failure. Pathogenic variants of desmoglein2 gene (DSG2) have been reported as genetic etiologies of AC. In contrast, many reported DSG2 variants are benign or variants of uncertain significance. Correct genetic variant classification is crucial for determining the best medical therapy for the patient and family members.
Methods
Pathogenicity of the DSG2 Ser194Leu variant that was identified by whole exome sequencing in a patient, who presented with ventricular tachycardia and was diagnosed with AC, was investigated by electron microscopy and immunohistochemical staining of endomyocardial biopsy sample.
Results
Electron microscopy demonstrated a widened gap in the adhering junction and a less well‐organized intercalated disk region in the mutated cardiomyocytes compared to the control. Immunohistochemical staining in the proband diagnosed with AC showed reduced expression of desmoglein 2 and connexin 43 and intercalated disc distortion. Reduced expression of DSG2 and Connexin 43 were observed in cellular cytoplasm and gap junctions. Additionally, we detected perinuclear accumulation of DSG2 and Connexin 43 in the proband sample.
Conclusion
Ser194Leu is a missense pathogenic mutation of DSG2 gene associated with arrhythmogenic left ventricular cardiomyopathy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Cardiology Division, Rambam Health Care Campus, Haifa, Israel.
- Department of Pathology, Rambam Health Care Campus, Haifa, Israel.
- Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
- Heart Institute, Hadassah Medical Center, Jerusalem, Israel.
- The Genetics Institute, Rambam Health Care Campus, Haifa, Israel.
- Medical Imaging Departments, Rambam Health Care Campus, Haifa, Israel.
ORCID profiles: Miry Blich
Cite
APA
Blich, M., Zohar, Y., Cohen-Kaplan, V., Minkov, I., Asleh, R., Horowitz-Cederboim, S., Weiss, K., Paperna, T., Lessick, J., Abadi, S., Khoury, A., Gepstein, L., Suleiman, M., & Caspi, O. (2024). Ser194Leu DSG2 mutation, associated with arrhythmogenic left ventricular cardiomyopathy and ventricular tachycardia. Pacing and Clinical Electrophysiology, 47(4), 503-510. https://doi.org/10.1111/pace.14950
Vancouver
Blich M, Zohar Y, Cohen-Kaplan V, Minkov I, Asleh R, Horowitz-Cederboim S, et al. Ser194Leu DSG2 mutation, associated with arrhythmogenic left ventricular cardiomyopathy and ventricular tachycardia. Pacing and Clinical Electrophysiology. 2024;47(4):503-510. doi:10.1111/pace.14950
BibTeX
@article{Blich2024,
author = {Blich, Miry and Zohar, Yaniv and Cohen-Kaplan, Victoria and Minkov, Irina and Asleh, Rabea and Horowitz-Cederboim, Smadar and Weiss, Karin and Paperna, Tamar and Lessick, Jonathan and Abadi, Sobhi and Khoury, Asaad and Gepstein, Lior and Suleiman, Mahmud and Caspi, Oren},
title = {Ser194Leu DSG2 mutation, associated with arrhythmogenic left ventricular cardiomyopathy and ventricular tachycardia},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
volume = {47},
number = {4},
pages = {503--510},
doi = {10.1111/pace.14950}
}
EUVIMED